KYORIN And Cyrano Therapeutics Enter Into An Option Agreement For CYR-064 For The Treatment Of Post-Viral Loss Of Smell In Japan
Agreement Provides Cyrano Therapeutics with Upfront and Milestone Payments, Plus Royalties from Commercialization of CYR-064 in Japan DELRA ...